Skip to main content

Exterior Artificial Pancreas Project- Crimson Publishers

Exterior Artificial Pancreas Project- Crimson Publishers

Objective: Pump size exterior artificial pancreas that will keep the glucose between 120-150mg/dl.

Method: The whole project based in idea that we should already know one insulin unit how much is able to go down the glucose and one glucagon’s unit how much is able to increase the glucose. Less than 120mg/dl it uses glucagon’s. More than 150mg/dl it uses insulin. The pump checks the glucose automatically every 8 minutes. The pump (which is software decision) will choose between insulin or glucagon’s base in internal database table with prerequisite glucose values and the insulin or glucagon’s units requiring for each glucose value (adaptive database table for each diabetic). The pump (the software) is able to choose how many insulin or glucagon’s units it should use (that is not based on what the diabetic will eat, but base on the current glucose level that received from the sensor which is located in human body, needle and sensor are one piece). The insulin should have work duration 8 minutes and works instantly.

Result: I chose 120mg/dl as the lowest allowance glucose level because this glucose level is secure for the diabetic (there is a time to prevent big hypoglycemia).

Conclusion: This project offers to diabetic’s insulin injections freedom, hypoglycemia prevention, run emergency tests, ideally for all ages, endocrinologists will have the software to adapt the internal database table of the pump for each diabetic needs.

https://crimsonpublishers.com/rmes/fulltext/RMES.000692.php

For more open access journals in crimson publishers Please click on link: https://crimsonpublishers.com

For more articles on Research in Medical & Engineering Sciences Please click on link: https://crimsonpublishers.com/rmes/

Comments

Popular posts from this blog

The Malachite Wen-Myeloid Sarcoma- Crimson Publishers

The Malachite Wen-Myeloid Sarcoma- Crimson Publishers   Contingent to World Health Organization (WHO) classification, myeloid sarcoma is denominated as a tumefaction comprised of myeloblasts amalgamated at an anatomical site divergent from the bone marrow which engenders distortion of normal tissue architecture. Generally, myeloid sarcoma is contemplated to be equivalent to and concurrent with acute myeloid leukaemia (AML), although lesions may occur in isolation. Additionally designated as granulocytic sarcoma, chloroma or extramedullary myeloid tumour, myeloid sarcoma categorically represents as a distinct tumefaction associated with architectural effacement of circumscribing soft tissue. Myeloid sarcoma may emerge as a de novo lesion or manifest as therapy related myeloid neoplasm or as disease progression within myeloproliferative neoplasm (MPN), myelodysplastic syndrome (MDS) or myelodysplastic / myeloproliferative neoplasm (MDS / MPN). In contrast, leukaemia cutis (LC) is...

Recent Developments of Decentralized Clinical Trial Technology in Korea- Crimson Publishers

Recent Developments of Decentralized Clinical Trial Technology in Korea- CrimsonPublishers   Clinical trials are routinely performed on human participants to evaluate the safety and effectiveness of new treatments such as drugs and medical devices. Recent advances in Information and Communication Technology (ICT) have led to the development of Decentralized Clinical Trials (DCTs). DCTs allow participants to participate in various types of clinical trials without having to visit hospitals. Data collection and frequent interactions between participants and medical staff can be possible via remote monitoring environments. In addition, the costs and time for clinical trials conduction can be significantly reduced. The development of ICT-based DCT technologies has already initiated. However, the adoption of DCTs was facilitated by the coronavirus disease 2019 (COVID-19) pandemic. Interest in and research on DCTs has also grown in Korea. This study describes the present state of DCT ...

Use of Thymbra Species Spreading in the Flora of Turkey for Medicinal Purposes- Crimson Publishers

Use of Thymbra Species Spreading in the Flora of Turkey for Medicinal Purposes- Crimson Publishers In terms of richness of plant species, Turkey has an important position in the world. It contains about 9,000 plant species and 11,500 taxa. Moreover, more than 1,000 plant species are used as medicinal and aromatic plants in our country. Medicinal plants are mostly evaluated by gathering from nature. Lamiaceae family covers many well-known and economically important medicinal types such as mint, sage, balm, thyme, lavender, basil. These plants, with wide adaptation limits, are well adapted to temperate and tropical regions. Although it is found in the natural flora of almost every region in our country, the Aegean and Mediterranean regions have an important position in terms of endemic species of the family. Although there are many aromatic plant species belonging to the family Lamiaceae described as thyme in Turkey, especially species containing the essential oil carvacrol and thymol ...